curcumin/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“Curcuminoids supplementation significantly decreased fasting blood glucose (p < 0.01), HbA1c (p = 0.031), and insulin resistance index (HOMA-IR) (p < 0.01) in type 2 diabetic patients.”
Quoted verbatim from Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.. - Study
- RCT
- Participants
- 100
- Duration
- 3 months
- Dose
- 300 mg/day
- Population
- overweight/obese adults with type 2 diabetes (BMI ≥ 24; fasting glucose ≥ 7.0 mmol/L or postprandial glucose ≥ 11.1 mmol/L)
Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial.2013PMID:22930403Permalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against HOMA-IR
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M310JMFT33XFTWMKRDYC7JZE